About Reagene Biosciences
Reagene Biosciences is a company based in Bengaluru (India) founded in 2016. Reagene Biosciences has raised $70.13 thousand across 2 funding rounds from investors including Suresh Poosala, Aruna Bayya and Dhanashri Girish Gudi. Reagene Biosciences operates in a competitive market with competitors including Abcam, Stem Cell Technologies, Meridian Bioscience, Teknova and Sangon Biotech, among others.
- Headquarter Bengaluru, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Reagene Biosciences Private Limited
- Date of Incorporation 01 Sep, 2016
- Jurisdiction Bengaluru, Karnataka, India
-
Annual Revenue
$21.26 K (USD)-76.85as on Mar 31, 2022
-
Net Profit
-$53.36 K (USD)-597.35as on Mar 31, 2022
-
EBITDA
-$50.2 K (USD)-620.76as on Mar 31, 2022
-
Total Equity Funding
$70.13 K (USD)
in 2 rounds
-
Latest Funding Round
$51.62 K (USD), Angel Round
Feb 16, 2020
-
Investors
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Reagene Biosciences
Reagene Biosciences has successfully raised a total of $70.13K across 2 strategic funding rounds. The most recent funding activity was a Angel Round of $51.62 thousand completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Reagene Biosciences
Reagene Biosciences has secured backing from 3 investors, including angel investors. Prominent investors backing the company include Suresh Poosala, Aruna Bayya and Dhanashri Girish Gudi.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
SP
Suresh Poosala |
Founder of Zluri, SaaS management platform, and active angel investor
|
Locked | Locked | Locked |
|
AB
Aruna Bayya |
-
|
Locked | Locked | Locked |
|
DG
Dhanashri Girish Gudi |
-
|
Locked | Locked | Locked |
Investor details for Reagene Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Reagene Biosciences
Investment portfolio details for Reagene Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Reagene Biosciences
Detailed financials for Reagene Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Reagene Biosciences Comparisons
Peer comparison for Reagene Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Reagene Biosciences
Reagene Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, Meridian Bioscience, Teknova and Sangon Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Molecular diagnostic device and kits
|
|
| Locked | Locked | Locked |
Molecular biology reagents and kits are supplied for research applications.
|
|
| Locked | Locked | Locked |
Research services, reagents, and kits for biotech applications are provided.
|
|
| Locked | Locked | Locked |
Bioreagents and assay kits are developed, with preclinical services provided.
|
Detailed competitors of Reagene Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Reagene Biosciences
Complete news archive for Reagene Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reagene Biosciences
Reagene Biosciences was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Reagene Biosciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Reagene Biosciences is a funded company, having raised a total of $70.13K across 2 funding rounds to date.
Annual revenue of Reagene Biosciences is $21.26K as on Mar 31, 2022.
Reagene Biosciences provides reagents for biochemistry, molecular biology, and cell cultures. The company has developed the platforms ReaGene Discovery Platform, ReaSkin, ReaADME (in vitro human assay), ReaPath(3D printed tissue for research), and ReaLite (assay and lab support). The ReaGEn, an FDA approved platform, offers translational 3D cell-based assays for drug discovery prior to animal studies.
Reagene Biosciences's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
Reagene Biosciences has 3 investors. Key investors include Suresh Poosala, Aruna Bayya, and Dhanashri Girish Gudi.
The valuation of Reagene Biosciences is $245.16K as of Feb 2020.